EUVIMEDEUVIMED entdecken
Crossref

A Calculated Risk: Evaluation of QTc Drug–Drug Interaction (DDI) Clinical Decision Support (CDS) Alerts and Performance of the Tisdale Risk Score Calculator

Rachel L Wasserman, Diane L Seger, Mary G Amato, Andrew Y Hwang, Julie Fiskio, David W Bates

Drug Safety · 2024

DOI: 10.1007/s40264-024-01466-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Safety, 2024. Verfasst von Rachel L Wasserman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Brigham and Women's Hospital, Boston, MA, USA. rwasserman@bwh.harvard.edu. Hauptthemen laut MEDLINE: Decision Support Systems, Clinical, Drug Interactions, Long QT Syndrome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: A risk factor for a potentially fatal ventricular arrhythmia Torsade de Pointes is a prolongation in the heart rate-corrected QT interval (QTc) ≥ 500 milliseconds (ms) or an increase of ≥ 60 ms from a patient's baseline value, which can cause sudden cardiac death. The Tisdale risk score calculator uses clinical variables to predict which hospitalized patients are at the highest risk for QTc prolongation. OBJECTIVE: To determine the rate of overridden QTc drug-drug interaction (DDI)-related clinical decision support (CDS) alerts per patient admission and the prevalence by Tisdale risk score category of these overridden alerts. Secondary outcome was to determine the rate of drug-induced QTc prolongation (diQTP) associated with overrides. METHODS: Our organization's enterprise data warehouse was used to retrospectively access QTc DDI alerts presented for patients aged ≥ 18 years who were admitted to Brigham and Women's Hospital during 2022. The QTc DDI CDS alerts were included if shown to a physician, fellow, resident, physician assistant, or nurse practitioner when entering the order in inpatient areas for patients with a length of stay of at least 2 days. Variables collected for the Tisdale calculator included age, sex, whether patient was on a loop diuretic, potassium level, admission QTc value, admitting diagnosis of acute myocardial infarction, sepsis, or heart failure, and number of QTc-prolonging drugs given to the patient. RESULTS: A total of 2649 patients with 3033 patient admissions had 18,432 QTc DDI alerts presented that were overridden. An average of 3 unique QTc DDI alerts were presented per patient admission and the alerts were overridden an average of 6 times per patient admission. Overall, 6% of patient admissions were low risk (score ≤ 6), 64% moderate risk (score 7-10), and 30% high risk (score ≥ 11) of QTc prolongation. The most common QTc DDI alerts overridden resulting in an diQTP were quetiapine and propofol (11%) and amiodarone and haloperidol (7%). The diQTP occurred in 883 of patient admissions (29%) and was more frequent in those with higher risk score, with 46% of patient admissions with diQTP in high risk, 23% in moderate risk, and 8% in low risk. CONCLUSION: Use of the Tisdale calculator to assess patient-specific risk of QT prolongation combined with CDS may improve overall alert quality and acceptance rate, which may decrease the diQTP rate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Decision Support Systems, ClinicalDrug InteractionsLong QT SyndromeHumansFemaleMaleMiddle AgedRetrospective StudiesAgedTorsades de PointesAdultElectrocardiographyRisk AssessmentRisk Factors

Autor:innen und Institutionen

  • Brigham and Women's Hospital, Boston, MA, USA. rwasserman@bwh.harvard.edu.
  • MCPHS University, Boston, MA, USA. rwasserman@bwh.harvard.edu.
  • Mass General Brigham, Somerville, MA, USA.
  • Brigham and Women's Hospital, Boston, MA, USA.
  • MCPHS University, Boston, MA, USA.
  • Harvard Medical School, Boston, MA, USA.

Zitieren

APA

Wasserman, R. L., Seger, D. L., Amato, M. G., Hwang, A. Y., Fiskio, J., & Bates, D. W. (2024). A Calculated Risk: Evaluation of QTc Drug–Drug Interaction (DDI) Clinical Decision Support (CDS) Alerts and Performance of the Tisdale Risk Score Calculator. Drug Safety. https://doi.org/10.1007/s40264-024-01466-w

Vancouver

Wasserman RL, Seger DL, Amato MG, Hwang AY, Fiskio J, Bates DW. A Calculated Risk: Evaluation of QTc Drug–Drug Interaction (DDI) Clinical Decision Support (CDS) Alerts and Performance of the Tisdale Risk Score Calculator. Drug Safety. 2024. doi:10.1007/s40264-024-01466-w

BibTeX
@article{Wasserman2024,
  author = {Wasserman, Rachel L and Seger, Diane L and Amato, Mary G and Hwang, Andrew Y and Fiskio, Julie and Bates, David W},
  title = {A Calculated Risk: Evaluation of QTc Drug–Drug Interaction (DDI) Clinical Decision Support (CDS) Alerts and Performance of the Tisdale Risk Score Calculator},
  journal = {Drug Safety},
  year = {2024},
  doi = {10.1007/s40264-024-01466-w}
}
Kostenlos starten →